Register entry

Kyowa Pharma Chemical Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
6
Live patents
0
Countries
1
Base
Japan
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Labelling1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Kyowa Pharma Chemical Co., Ltd.530 Chokeiji, Takaoka, Toyama 933-8511, Japan (JPN)Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging3003128853690852371
Catalogue

Drug listings by form and route

6

6 active NDC listings: 6 bulk ingredient. By marketing category: BULK INGREDIENT 6.

Dosage formNDCs
powder5
liquid1
RouteNDCs
Labeller name on the listingNDCs
kyowa pharma chemical co., ltd.6
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
-Bimatoprostpowder12079-1067BULK INGREDIENT
-Dinoprostonepowder12079-0485BULK INGREDIENT
-Istradefyllinepowder12079-2003BULK INGREDIENT
-Latanoprostliquid12079-0475BULK INGREDIENT
-Olopatadine Hydrochloridepowder12079-2002BULK INGREDIENT
-Tranexamic Acidpowder12079-2001BULK INGREDIENT
Neighbours

Registered in the same town

1
Compare

Comparable companies in Japan

Enquiry

Common questions

Is Kyowa Pharma Chemical Co., Ltd. FDA approved?
Kyowa Pharma Chemical Co., Ltd. holds 1 FDA-registered establishment in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Kyowa Pharma Chemical Co., Ltd.'s drugs manufactured?
The FDA register lists Takaoka. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, packaging.
What drugs does Kyowa Pharma Chemical Co., Ltd. make?
6 products are listed under Kyowa Pharma Chemical Co., Ltd. in the openFDA NDC Directory, most often as powder; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.